drugset / Trial / NCT03238300

Neuroscience-Informed Treatment Development for Adolescent Alcohol Use

NCT03238300 ↗

RandomizedCrossoverDouble-blindBasic science

Summary

This study will examine the effect of N-Acetylcysteine (NAC), an over-the-counter antioxidant supplement, on brains of youth (ages 15-19) using magnetic resonance imaging (MRI).

Timeline

Start
2017-10-16
Primary completion
2022-03-01
Completion
2022-03-01

Outcome

Missed primary endpoint

registry analysis (superiority test); N-Acetylcysteine vs Placebo; p >0.05 NCT03238300 ↗

registry analysis (superiority test); N-Acetylcysteine vs Placebo Oral Capsule; p >0.05 NCT03238300 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1200 mg Oral